Table 2 Light at night at recruitment and risk of breast cancer, by menopausal status and oestrogen-receptor status of breast cancer
Oestrogen-receptor status of breast cancer | |||||||||
---|---|---|---|---|---|---|---|---|---|
All breast cancers | Positive | Negative | |||||||
LAN level a | No. cases | HR (95% CI) b | P -value | No. cases | HR (95% CI) b | P -value | No. cases | HR (95% CI) b | P -value |
Total (Pyrs=640 832) | |||||||||
Low | 416 | 1.00 | 330 | 1.00 | 54 | 1.00 | |||
Med | 847 | 1.00 (0.89–1.12) | 0.97 | 661 | 0.99 (0.87–1.13) | 0.88 | 134 | 1.20 (0.88–1.65) | 0.26 |
High | 512 | 1.01 (0.88–1.15) | 0.92 | 391 | 0.98 (0.84–1.14) | 0.78 | 77 | 1.16 (0.82–1.65) | 0.40 |
Pre-menopausal breast cancer (Pyrs=373 323) | |||||||||
Low | 145 | 1.00 | 115 | 1.00 | 19 | 1.00 | |||
Med | 326 | 0.91 (0.74–1.10) | 0.33 | 250 | 0.89 (0.71–1.11) | 0.30 | 53 | 1.09 (0.64–1.84) | 0.75 |
High | 219 | 1.00 (0.81–1.24) | 1.00 | 165 | 0.97 (0.76–1.24) | 0.82 | 31 | 1.04 (0.59–1.85) | 0.89 |
Post-menopausal breast cancer (Pyrs=267 509) | |||||||||
Low | 271 | 1.00 | 215 | 1.00 | 35 | 1.00 | |||
Med | 521 | 1.05 (0.91–1.22) | 0.48 | 411 | 1.05 (0.89–1.24) | 0.55 | 81 | 1.26 (0.84–1.87) | 0.26 |
High | 293 | 1.00 (0.85–1.18) | 1.00 | 226 | 0.97 (0.81–1.17) | 0.77 | 46 | 1.23 (0.79–1.92) | 0.36 |